EKIMAS Corporation does not have significant operations. Previously, the company was engaged in the development of polymer materials for use in the design and development of medical devices used for treating a range of anatomical sites and disease states. It intends to identify, acquire, or merge with an operating company through an equity-based exchange transaction. The company was formerly known as AdvanSource Biomaterials Corporation and changed its name to EKIMAS Corporation in March 2020. EKIMAS Corporation was incorporated in 1993 and is based in Las Vegas, Nevada.
Show more...
FAQ
AdvanSource Biomaterials 今天的股價是多少?▼
ASNB 目前價格為 $0.85 USD,過去 24 小時上漲了 +6.58%。在圖表上更密切關注 AdvanSource Biomaterials 股價表現。
AdvanSource Biomaterials 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,AdvanSource Biomaterials 的股票以代號 ASNB 進行交易。
AdvanSource Biomaterials 的市值是多少?▼
今天 AdvanSource Biomaterials 的市值為 4.83M
AdvanSource Biomaterials 上一季度的財報如何?▼
ASNB 上一季度的財報為每股 -0.01 USD,預估為 不適用 USD,帶來 不適用 的驚喜。下一季度的預估財報為每股 不適用 USD。
AdvanSource Biomaterials 去年的營收是多少?▼
AdvanSource Biomaterials 去年的營收為 0USD。
AdvanSource Biomaterials 去年的淨利是多少?▼
ASNB 去年的淨收益為 -5.99MUSD。
AdvanSource Biomaterials 會發放股息嗎?▼
是的,ASNB 的股息每 zh-tw 發放一次。每股最新股息為 0.18 USD。截至今日,股息殖利率(FWD)% 為 0%。
AdvanSource Biomaterials 有多少名員工?▼
截至 April 01, 2026,公司共有 11 名員工。
AdvanSource Biomaterials 位於哪個產業?▼
AdvanSource Biomaterials從事於Manufacturing產業。
AdvanSource Biomaterials 何時完成拆股?▼
AdvanSource Biomaterials 最近沒有進行任何拆股。